Cholesterol Management Supplement Found to Contain Undeclared Rx Ingredient
Cholestene, a dietary supplement marketed for cholesterol management, has been found to contain a hidden drug ingredient, according to the Food and Drug Administration.
Dyslipidemia
HOPE-3 Trial: Lasting Effect of Rosuvastatin Prevents Major Cardiovascular Events
HOPE-3 was designed to assess if reducing BP and/or LDL-C would reduce cardiovascular events in study participants at intermediate risk with no prior cardiovascular events.
Resmetirom Reduces Hepatic Fat, Lipid Levels in Patients With Hypothyroidism and Nonalcoholic Steatohepatitis
Investigators report results from MAESTRO-NAFLD-1, a phase 3, randomized, double-blind, placebo-controlled trial evaluating the effect of treatment with resmetirom in patients with hypothyroidism and nonalcoholic steatohepatitis.
Carotid Plaque Instability Risk Higher in Women With Metabolic Syndrome, Hypertriglyceridemia
This study aimed to assess the effects of the various elements of metabolic syndrome on carotid plaque destabilization.
Fish Oil Products: Do The Serving Sizes Add Up to Cholesterol Benefits?
Omega-3 fatty acids, including eicosapentaenoic acid (EPA) and docosehexaenoic acid (DHA), have been found to be associated with cardiovascular health benefits.
Dyslipidemia Drug Indications
Comparative chart of single and combination treatment options indicating which lipids can be targeted for dyslipidemias.
Case Series: Insulin Infusions for Severe Hypertriglyceridemia With COVID-19
Findings of the review showed that continuous insulin infusion, coupled with standard oral lipid lowering therapies, successfully treated the hypertriglyceridemia.
Managing the Interplay of Familial Hypercholesterolemia and COVID-19
About 90% of those with familial hypercholesterolemia have not been diagnosed or treated for it, leaving them more vulnerable for COVID-19 infection and its complications.
Inclisiran Safe, Effective in Reducing LDL-C in Patients With Familial Hypercholesterolemia or ASCVD
Researchers conducted a patient-level pooled analysis from phase 3 trials of inclisiran in patients with familial hypercholesterolemia or ASCVD.
Thyroid Functioning Biomarkers May be Related to Blood Lipid Profiles
Observational studies using Mendelian randomization have demonstrated a causal relationship between normal range thyroid stimulating hormone (TSH) levels and blood lipids. In this featured study, researchers attempt to show a causal relationship between thyroid function and lipids.
- Loading...
Loading...
Loading... 
Loading...